I am a
Home I AM A Search Login

Papers of the Week

Papers: 2 Feb 2019 - 8 Feb 2019

Human Studies, Pharmacology/Drug Development

2019 Feb

Am J Addict



No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.



It is presently unclear whether extended-release naltrexone hydrochloride treatment induces pain or aggravates existing pain among individuals with opioid use disorders. We assessed changes in pain among individuals receiving treatment with either extended-release naltrexone hydrochloride or buprenorphine-naloxone hydrochloride.